SEC Form 4 · accession 0001104659-16-102273
VERACYTE, INC. · VCYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie Brooks
Officer — EVP, Gen. Counsel & Secretary
Period of report
Mar 1, 2016
Accepted (ET)
Mar 3, 2016 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001384101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 29, 2016 | A | 281 | $5.508 | A | 3,403 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2 | $6.45 | Mar 1, 2016 | A | 50,000 | A | — | Mar 1, 2026 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
- F2The option becomes exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.